Skip to main content
. 2022 Feb 18;11(4):549. doi: 10.3390/plants11040549

Table 2.

Modulatory Mechanisms of Phytochemicals used to Treat PD Based on in-silico Computational Predictions and Reported in-vitro and in-vivo Studies.

Compound Names Compound Natural Sources In-Silico Anti-inflammatory Prediction Modulatory Mechanism of Microglia Polarization
Pa Pi In-Vitro In-Vivo
Capsaicin Capsicum 0.266 0.196 - Elevation of the expression of ciliary neurotrophic factor receptor alpha [CNTFRα] [103]
Reduction of NO, iNOS, and IL-6 expressions, and elevation of Arg-1 and macrophage mannose receptor (CD206) [104]
Reduction of TNF-α and IL-1β expressions [105]
α-asarone Acorus tatarinowii 0.592 0.033 Inhibition of NF-κB [106] Inhibition of NF-κB [106]
Galangin Alpinia officinarum 0.689 0.017 Inhibition of MAPK and NF-κB signaling pathways [107]
Inhibition of TNF-α, IL-6, IL-1β, and COX-2 through JNK and NF-κB pathways [108]
Inhibition of TNF-α, IL-6, IL-1β, and COX-2 through JNK and NF-κB pathways [108]
Biochanin A Legume plants 0.588 0.034 Inhibition of TNF-α and IL-1β through MAPK pathway [109] Inhibition of TNF-α and IL-1β through MAPK pathway [109]
Baicalein Scutellaria baicalensis Georgi 0.674 0.019 Inhibition of TNF-α and IL-6 through MAPK and NF-κB signaling pathways [110] Suppression of NLRP3/caspase-1/GSDMD pathway [101]
Apocynin Picrorhiza kurroa 0.496 0.058 - Inhibition of STAT1 and NF-κB pathways [111]
α-Mangostin Mangosteen pericarp 0.694 0.017 Inhibition of NF-κB pathway [112] Reduction of IL-6 and COX-2 [113]
Myricetin Turbinaria ornata 0.720 0.013 Inhibition of MAPK and NF-κB signaling pathways [114] Inhibition of MAPK and NF-κB signaling pathways [114]
Myricitrin Myrica cerifera 0.762 0.009 - Suppression of TNF-α [115]
Icariin Herba epimedii 0.732 0.012 Reduction of TNF- α, IL-1β and NO through inhibition of NF-κB pathway [116] Reduction of TNF- α, IL-1β and NO through inhibition of NF-κB pathway [116]
Nobiletin Citrus fruits 0.694 0.017 Suppression of TNF-α, IL-1β and NO through inhibition of NF-κB pathway [117] Attenuation of IL-1β production [118]
Tenuigenin Polygala tenuifolia 0.841 0.005 Inhibition of NLRP3 inflammasome and downregulation of caspase-1, pro-IL-1β, and IL-1β [102] Suppression of NLRP3 inflammasome [102]
Tanshinone I Radix salviae miltiorrhizae 0.515 0.053 Suppression of TNF-α, IL-6, and IL-1β [119] Attenuation of the increase of TNF-α, and reserving the increase of IL-10 [119]
Salvianolic acid B Salviae miltiorrhizae 0.313 0.149 Reduction of TNF-α, IL-1β and NO productions [120] Attenuation of the expressions of TNF-α, IL-1β, and NO [120]
Licochalcone E Glycyrrhiza inflata 0.523 0.050 Activation of Nrf2/ARE-dependent pathway [107] Activation of Nrf2/ARE-dependent pathway [107]
Licochalcone A Glycyrrhiza inflata 0.740 0.011 Inhibition of ERK1/2 and NF-κB p65 through reduction of iNOS, COX-2, TNF-α, IL-1β, and IL-6 expressions [121] Inhibition of ERK1/2 and NF-κB p65 through reduction of iNOS, COX-2, TNF-α, IL-1β, and IL-6 expressions [121]
Isobavachalcone Psoralea corylifolia 0.778 0.008 Inhibition of NF-κB pathway through inhibition of TNF-α, IL-6, IL-1β, and IL-10 [122] Reduction of IL-6 and IL-1β expressions [122]
Macelignan Myristica fragrans 0.352 0.121 Suppression of MAPKs and NF-kB via the regulation of IkB [123] Activation of PPAR-γ [124]
Ginsenoside Rg1 Panax ginseng 0.801 0.007 Inhibition of NF-κB and MAPK signaling pathways through attenuation of TNF-α, IL-1β, iNOS, and COX-2 mRNA and protein levels [125] Inhibition of NF-κB and MAPK signaling pathways through reduction of TNF-α, IL-1β, and IL-6 [126]
Tripchlorolide Tripterygium wilfordii Hook F 0.791 0.007 Attenuation of TNF-α, IL-1β, NO, iNOS, PGE2, and COX-2 [127] -
Triptolide Tripterygium wilfordii Hook F 0.698 0.016 Downregulation of NO, iNOS, TNF-α, and IL-1β [128] -
Naringin Grapefruit, Citrus fruits 0.700 0.016 - Inhibition of IL-1β [129]
Attenuation of TNF-α [130]

NA: not applicable.